Covid-19 Vaccine

COVID Vaccine's 'Precaution' Dose To Be Now Available For Adults From 10 April At Private Vaccination Centres: Govt
COVID Vaccine's 'Precaution' Dose To Be Now Available For Adults From 10 April At Private Vaccination Centres: GovtSwarajya StaffApr 8, 2022 03:22 PM +05:30 IST
COVID-19 Vaccination: Over 148 Crore Vaccine Doses Provided To States And UTs So Far, Says Centre
COVID-19 Vaccination: Over 148 Crore Vaccine Doses Provided To States And UTs So Far, Says CentreSwarajya StaffDec 25, 2021 01:12 PM +05:30 IST
Explained: The Debate Over If, When And How Of Covid-19 Vaccine Booster Shots In India
Explained: The Debate Over If, When And How Of Covid-19 Vaccine Booster Shots In IndiaSwarajya StaffDec 15, 2021 12:18 PM +05:30 IST
Over 140 Crore COVID-19 Vaccine Doses Provided To States, UTs So Far: Centre
Over 140 Crore COVID-19 Vaccine Doses Provided To States, UTs So Far: CentreSwarajya StaffDec 10, 2021 12:11 PM +05:30 IST
Over 22.7 Crore Balance, Unutilised COVID-19 Vaccine Doses Still Available With States, UTs: Centre
Over 22.7 Crore Balance, Unutilised COVID-19 Vaccine Doses Still Available With States, UTs: CentreSwarajya StaffNov 26, 2021 11:36 AM +05:30 IST
Over 131 Crore COVID-19 Vaccine Doses Provided To States, UTs So Far: Union Health Ministry
Over 131 Crore COVID-19 Vaccine Doses Provided To States, UTs So Far: Union Health MinistrySwarajya StaffNov 24, 2021 12:26 PM +05:30 IST
Over 20.91 Crore Balance, Unutilised COVID Vaccine Doses Still Available With States And UTs: Union Health Ministry
Over 20.91 Crore Balance, Unutilised COVID Vaccine Doses Still Available With States And UTs: Union Health MinistrySwarajya StaffNov 17, 2021 10:21 AM +05:30 IST
Bharat Biotech Chairman Dr Krishna Ella Slams Biased Media Coverage And Domestic Politics Around Covaxin: "It Really Hurts"
Bharat Biotech Chairman Dr Krishna Ella Slams Biased Media Coverage And Domestic Politics Around Covaxin: "It Really Hurts"Swarajya StaffNov 12, 2021 03:34 PM +05:30 IST
Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAX
Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAXPTIOct 30, 2021 10:03 AM +05:30 IST
More Than 96.75 Crore COVID-19 Vaccine Doses Have Been Provided To States, UTs: Centre
More Than 96.75 Crore COVID-19 Vaccine Doses Have Been Provided To States, UTs: CentrePTIOct 11, 2021 10:32 AM +05:30 IST
Final Decision On Approval To Bharat Biotech's Covaxin To Be Taken Next Week: WHO
Final Decision On Approval To Bharat Biotech's Covaxin To Be Taken Next Week: WHOSwarajya StaffOct 6, 2021 10:38 AM +05:30 IST
With Increasing Domestic Production Of COVID-19 Vaccines, Govt Unlikely To Procure Pfizer, Moderna Jabs: Report
With Increasing Domestic Production Of COVID-19 Vaccines, Govt Unlikely To Procure Pfizer, Moderna Jabs: ReportSwarajya StaffSep 23, 2021 10:29 AM +05:30 IST
Over 4.52 Crore COVID Vaccine Doses Still Available With States And UTs, 48 Lakh More Shots In Pipeline: Centre
Over 4.52 Crore COVID Vaccine Doses Still Available With States And UTs, 48 Lakh More Shots In Pipeline: CentreSwarajya StaffSep 22, 2021 11:40 AM +05:30 IST
COVID-19 Vaccination: India Sets World Record Of Administering Over 2.5 Crore Vaccine Doses In A Day
COVID-19 Vaccination: India Sets World Record Of Administering Over 2.5 Crore Vaccine Doses In A DayIANSSep 18, 2021 08:31 AM +05:30 IST
Dr Reddy's Gets DCGI Approval For Phase 3 Bridging Trials Of Single-Dose Sputnik Light Covid-19 Vaccine
Dr Reddy's Gets DCGI Approval For Phase 3 Bridging Trials Of Single-Dose Sputnik Light Covid-19 VaccineSwarajya StaffSep 15, 2021 12:45 PM +05:30 IST
Explained In Charts: The Status Of Vaccination Coverage In Urban Districts With India’s Most Populous Cities
Explained In Charts: The Status Of Vaccination Coverage In Urban Districts With India’s Most Populous CitiesSwarajya StaffSep 4, 2021 06:00 PM +05:30 IST
Over 4.49 Crore COVID-19 Vaccine Doses Still Available With States And UTs, 85.63 Lakh More Shots In Pipeline: Centre
Over 4.49 Crore COVID-19 Vaccine Doses Still Available With States And UTs, 85.63 Lakh More Shots In Pipeline: CentreSwarajya StaffSep 4, 2021 12:32 PM +05:30 IST
Hyderabad-Based Biological E Gets DCGI Nod To Conduct Phase 2/3 Clinical Trials Of Its COVID-19 Vaccine On Children
Hyderabad-Based Biological E Gets DCGI Nod To Conduct Phase 2/3 Clinical Trials Of Its COVID-19 Vaccine On ChildrenIANSSep 2, 2021 12:45 PM +05:30 IST
ZyCoV-D: India's Homegrown Three-Dose Covid-19 Vaccine For Anyone Over 12, Approved For Emergency Use
ZyCoV-D: India's Homegrown Three-Dose Covid-19 Vaccine For Anyone Over 12, Approved For Emergency UseKaran KambleAug 21, 2021 05:14 AM +05:30 IST
Moderna COVID-19 Vaccine 76 Per Cent Effective Against Delta Variant, Pfizer 42 Per Cent: Study
Moderna COVID-19 Vaccine 76 Per Cent Effective Against Delta Variant, Pfizer 42 Per Cent: StudyIANSAug 12, 2021 04:30 PM +05:30 IST
Load More